Doctor profile · Federal record
Dr. ERIC BREWER, ARNP
Family Nurse Practitioner (CMS: NURSE PRACTITIONER) · PENSACOLA, FL
- NPI 1275957912
- Accepts Medicare
- 13 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9400 UNIVERSITY PKWY, SUITE 210
PENSACOLA, FL 325145752
(850) 944-7256
Credentials & registration
- NPI registered
- February 2014 — 12 yrs on file
- Profile last updated
- April 30, 2021
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Florida #APRN9249353
- Medicaid
- FL #015883400
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275957912. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
372
Distinct HCPCS
5
Medicare allowed
$31,968
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 149 | 118 | $83 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 102 | 78 | $57 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 88 | 88 | $109 | |
G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 20 | 20 | $139 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 13 | 13 | $114 |
In context: peer comparison
Among 69 peers in this city , average services per provider: 142. This provider delivers 2.6× the peer median.Open Payments
Industry payments received
All-time total
$1,739
Transactions
104
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 23 | $339.74 | |
| ABBVIE INC. | 24 | $227.77 | |
| AstraZeneca Pharmaceuticals LP | 11 | $213.70 | |
| PFIZER INC. | 8 | $160.44 | |
| Lilly USA, LLC | 9 | $142.28 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $141.24 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $113.41 | |
| Abbott Laboratories | 2 | $102.32 | |
| Phathom Pharmaceuticals, Inc. | 5 | $76.87 | |
| Amgen Inc. | 3 | $43.29 | |
| Lundbeck LLC | 2 | $41.40 | |
| Astellas Pharma US Inc | 2 | $39.85 | |
| Antares Pharma, Inc. | 2 | $33.05 | |
| AIMMUNE THERAPEUTICS, INC. | 1 | $17.18 | |
| Esperion Therapeutics, Inc. | 1 | $16.56 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,163
Patients
393
Total drug cost
$18,988
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Amlodipine Besylate | Generic | 122 | 45 | $1,458 |
| Omeprazole | Generic | 108 | 41 | $1,932 |
| Losartan Potassium | Generic | 103 | 33 | $2,239 |
| Metformin Hcl | Generic | 100 | 34 | $1,313 |
| Levothyroxine Sodium | Generic | 91 | 30 | $1,484 |
| Hydrochlorothiazide | Generic | 89 | 26 | $662 |
| Lisinopril | Generic | 80 | 28 | $1,035 |
| Montelukast Sodium | Generic | 77 | 29 | $1,501 |
| Pantoprazole Sodium | Generic | 74 | 27 | $1,310 |
| Levocetirizine Dihydrochloride | Generic | 73 | 29 | $1,521 |